Investing.com -- Shares of Tempest Therapeutics Inc (NASDAQ: TPST) climbed 5.3% following the announcement that the European Medicines Agency (EMA) has granted Orphan Drug Designation to its cancer ...

This surge in natural gas inventories not only surpassed the forecasted number, but also registered a notable increase from the previous week’s figure of 101 Bcf. This indicates a weaker demand for ...

The Wisconsin Supreme Court in 2024 rejected the tax exemption bid by Catholic Charities Bureau and its subsidiaries.

Investing.com -- BofA Global Research reiterated its bearish stance on the U.S. dollar in a note Thursday, even as it ...

Brown-Forman Corp missed Wall Street estimates for first-quarter earnings and revenue and warned of a tough year ahead, ...

The bill seeks to extend tax breaks, set during Trump’s first term in 2017 and on track to expire at the end of 2025, for multinational corporations. It is also expected to fulfill many of Trump’s ...

One reason Tesla shares performed well last month was Elon Musk’s decision to step back from President Trump’s DOGE initiative. During the company’s Q1 earnings call, Musk said he would be spending “a ...

The brokerage forecasts Dr Reddy’s semaglutide revenues at $280 million in 2027, contributing about 18% of the company’s ...